KalVista Pharmaceuticals ...

NASDAQ: KALV · Real-Time Price · USD
12.89
-0.06 (-0.46%)
At close: Aug 15, 2025, 3:59 PM
13.13
1.82%
After-hours: Aug 15, 2025, 07:39 PM EDT

KalVista Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Apr 30, 2025 Apr 30, 2024 Apr 30, 2023 Apr 30, 2022 Apr 30, 2021
Cash & Equivalents
98.64M 31.79M 56.24M 30.73M 50.59M
Short-Term Investments
89M 178.61M 93.14M 135.47M 198.34M
Long-Term Investments
n/a n/a n/a n/a n/a
Other Long-Term Assets
7.09M 567K 106K 193K 200K
Receivables
n/a 10.87M 16.57M n/a 10.42M
Inventory
n/a n/a n/a 2.71M n/a
Other Current Assets
34.35M n/a n/a n/a n/a
Total Current Assets
241.69M 225.69M 172.33M 193.65M 264.26M
Property-Plant & Equipment
1.99M 9.15M 10.77M 10.04M 7.55M
Goodwill & Intangibles
n/a n/a n/a n/a n/a
Total Long-Term Assets
9.08M 9.71M 10.88M 10.23M 7.75M
Total Assets
250.77M 235.4M 183.2M 203.88M 272.01M
Account Payables
4.88M 9.11M 4.82M 3.64M 1.98M
Deferred Revenue
11M n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a
Other Current Liabilities
n/a 6.69M n/a n/a n/a
Total Current Liabilities
45.17M 22.81M 15.03M 11.58M 9.77M
Long-Term Debt
n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a
Total Long-Term Liabilities
110.21M 6.01M 7.14M 7.21M 5.05M
Total Liabilities
155.38M 28.82M 22.18M 18.79M 14.82M
Total Debt
6.31M 7.32M 8.23M 8.19M 5.91M
Common Stock
50K 42K 34K 25K 24K
Retained Earnings
-653.17M -469.73M -343.08M -250.18M -167.84M
Comprehensive Income
-5.21M -3.49M -3.06M -3.86M -1.43M
Shareholders Equity
95.39M 206.58M 161.03M 185.09M 257.19M
Total Investments
89M 178.61M 93.14M 135.47M 198.34M